burden of heart failure burden of heart failure in the u.s. aha, 1998 heart and statistical update...

33
Burden of Heart Failure Paul Heidenreich MD, MS Director, CHF QUERI

Upload: buixuyen

Post on 27-Jun-2018

215 views

Category:

Documents


0 download

TRANSCRIPT

Burden of Heart Failure

Paul Heidenreich MD, MS

Director, CHF QUERI

Background on

U.S. Heart Failure

Population

Group Prevalence Incidence Mortality

Hospital

Discharges Cost

Total

population 5,300,000 660,000 284,965 1,084,000

$34.8

billion

1American Heart Association. 2008 Heart and Stroke Statistical

Update. Dallas, TX: American Heart Association; 2008. 2Hunt SA et al. ACC/AHA guidelines for the evaluation and

management of chronic heart failure in the adult. 2001.

VA prevalence near 140,000 or 2.6%

Projected Prevalence of Heart

Failure

Heidenreich, Circulation 2011

U.S. HF Hospitalization Rate

Principal Diagnosis

NHDS

0

20,000

40,000

60,000

80,000

100,000

120,000

140,000

160,000

180,000

200,000

2002 2003 2004 2005 2006 2007 2008 2009

Pat

ien

ts p

er

Yea

r

Fiscal Year

Stable Number of Veteran Outpatients with Heart Failure

0

100,000

200,000

300,000

400,000

500,000

600,000

700,000

800,000

900,000

1,000,000

2002 2003 2004 2005 2006 2007 2008 2009

Pat

ien

t vi

sits

pe

r Ye

ar

Fiscal Year

Increasing VA Burden:Outpatient Encounters for Heart Failure

Estimated Direct and Indirect Costs of HF in US

8%

8% 10%

7%

14%

53%

Hospitalization

$18.8

Lost Productivity/

Mortality*

$3.1

Home Healthcare

$3.2

Drugs/Other

Medical Durables

$3.1

Physicians/Other

Professionals

$2.3

Nursing Home

$4.3

*Lost future earnings of persons who will die in 2008,

discounted by 3%AHA. Heart Disease and

Stroke Statistics—2008 Update

Total Cost

$34.8 billion

Cost Following HF Diagnosis:

Surviving < 12 months

Dunlay, Circ CQO, 2011

Cost Following Diagnosis: Long

Term Survivors

Dunlay, Circ CQO, 2011

Increasing Burden of Heart

Failure in the U.S.

AHA, 1998 Heart and Statistical Update

NCHS, National Center for Health Statistics

Projected Costs of Heart Failure

Heidenreich, Circulation 2011

Mortality: US Medicare

Buenos, Circulation 2009

VA Trends in Mortality

Heidenreich JACC, 2010

30-Day Readmission Rate: US

Medicare

VA Trends in Readmission

Heidenreich JACC, 2010

30-Day Readmissions (All Cause)

Distribution for VA Facilities

Excludes Facilities with < 100 HF discharges over 2 years.

30-Day Readmissions (HF Principal

Dx) Distribution for VA Facilities

Excludes Facilities with < 100 HF discharges over 2 years.

30-Day Mortality Distribution for

VA Facilities

Excludes Facilities with < 100 HF discharges over 2 years.

VISN 30-Day Outcome Following

a Heart Failure Discharge

VISN

Krumholz, H. M. et al. Circ Cardiovasc Qual Outcomes 2009;2:407-413

Heart failure 30-day Risk-Standardized Readmission Rate Distribution

Goal

Mortality and Readmissions

Gorodeski, NEJM 2010, 363 (3) 297

Mortality vs. Readmissions

0.0

0.2

0.4

0.6

0.8

1.0

1.2

1.4

1.6

Ad

juste

d O

dd

s R

ati

o f

or

Ou

tco

me

Decre

ased

In

cre

ased

2003 2004 2005 2006

30-Day HF

Rehospitalization

30-Day Mortality

2002

Heidenreich, JACC 2010

Hospital HF Volume, Outcome, Cost

Joynt, Annals of Internal Medicine 2011

Mortality at 30 Days

Hospital Compare 2012

Treatments for Heart Failure

90 91 92 93 94 95 96 97 98 99 00 01 02 03

Hydralazine-nitrates

ACE inhibitors

Beta blockers

Aldo blockers

ARBs

VADs

CRT

ICDs

Diuretics

Heart Failure Society of America

Digoxin

2005 Performance data for VA and

Non-VA (Joint Commission mean)

for Heart Failure Mission Critical

Measures.

0

20

40

60

80

100

ACE Inhibitor Pt. Education Smoking Counseling LVEF documentation

VA Joint Commission

Improvement in Medicare

Process of Care

Fonarow, Peterson, JAMA 2009

2007 Performance Data for VA and the

Non-VA (Joint Commission mean) for

HF Mission Critical Measures.

0

20

40

60

80

100

ACE Inhibitor Pt. Education Smoking Counseling LVEF documentation

VA Joint Commission

2005 Performance data for VA and

Non-VA (Joint Commission mean)

for Heart Failure Mission Critical

Measures.

0

20

40

60

80

100

ACE Inhibitor Pt. Education Smoking Counseling LVEF documentation

VA Joint Commission

2007 Performance Data for VA and the

Non-VA (Joint Commission mean) for

HF Mission Critical Measures.

0

20

40

60

80

100

ACE Inhibitor Pt. Education Smoking Counseling LVEF documentation

VA Joint Commission

Summary

VA burden of heart failure care is growing

Aging of the population will likely

continue/accelerate this growth

VA led in process of care but the rest of

the country has caught up.

Finding “preventable” costs/admissions is

increasingly difficult